2'-DEOXYCOFORMYCIN - A NEW ANTI-CANCER AGENT
- 1 January 1981
- journal article
- research article
- Vol. 4 (2) , 209-213
Abstract
2''-Deoxycoformycin (2''-dCF) is a powerful inhibitor of adenosine deaminase (ADA), an enzyme found in high concentrations in lymphoid tissue. Although inactive in preclinical [vertebrate] tumor models, 2''-dCF has shown clinical antitumor activity as a single agent in lymphoid malignancies. This drug has the added potential of being useful as a potentiator of other antitumor agents which are deactivated by ADA. It is also possible that the drug has potential as an immunosuppressive agent. Phase I [human] studies are ongoing and phase II trials are planned to define the antitumor spectrum of this agent.This publication has 5 references indexed in Scilit:
- TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA WITH 2'-DEOXYCOFORMYCIN - CLINICAL AND BIOCHEMICAL CONSEQUENCES OF ADENOSINE-DEAMINASE INHIBITION1979
- Adenosine Deaminase Activity in Acute Lymphoblastic Leukaemia: Cytochemical, Immunological and Clinical CorrelationsScandinavian Journal of Haematology, 1978
- Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency diseaseCell, 1978
- Enhancement of the biological activity of cordycepin (3'-deoxyadenosine) by the adenosine deaminase inhibitor 2'-deoxycoformycinBiochemical Pharmacology, 1976
- ENHANCEMENT OF 9-BETA-D-ARABINOFURANOSYLADENINE CYTOTOXICITY TO MOUSE LEUKEMIA-L1210 INVITRO BY 2'-DEOXYCOFORMYCIN1976